Johnson & Johnson’s medical device and diagnostics segment outshone the group’s other segments by posting a solid revenue increase in the second fiscal quarter. Medtech revenue for the quarter was $6.13bn, up 4% on the same period in fiscal 2009. J&J’s ...
Please Login to read the full article.
